PREEMIE Reauthorization Act

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA H.R. 2194/S. 1221 Gestational Diabetes Act Newborn Screening Saves Lives Act Reauthorization (not introduced) Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $60,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

HR2679/S.1440, Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act, preterm births Birth Defects Prevention, Risk Reduction, and Awareness Act, birth defects prevention. HR2194/S1221, Gestational Diabetes Act of 2011; HR3418/S1862 Stillbirth and SUID Prevention, Education and Awareness Act of 2011; maternity care.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $900,742 · Firm income: Not reported

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $900,742 · Firm income: Not reported

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA H.R. 2194/S. 1221 Gestational Diabetes Act Newborn Screening Saves Lives Act Reauthorization (not introduced) Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $50,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to Medicaid coverage and reimbursement of biologics; securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; biologics data exclusivity; clinical trial and testing issues; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.

Client expense: $190,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

National HIV/AIDS Strategy (general); Emergency Contraception (general); H.R. 2679/S. 1440, PREEMIE. H.R. 2954, Health Equity Accountability Act; HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Health IT (general); H.R. 2029/ S.1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); The Meaningful End to Defensive Medicine and Aimless Lawsuits; H.R. 2127, Newborn Act; H.R. 5/ S.1099, HEALTH Act; H.R. 452, Medicare Decisions Accountability Act of 2011; S.668, Health Care Bureaucrats Elimination Act; H.R.666, Birth Certificate Enhancement Act of 2011; H.R. 894, Maternal Health Accountability Act; Imaging (general); H.R. 2194/ S.1221, GEDI Act; H.R. 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); H.R. 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; H.R. 2085/ S. 1214; Essential Health Benefits (general); Graduate Medical Education (general); H.R. 3418/ S. 1862, Stillbirth & SUID Prevention, Education & Awareness Act; Quality Improvement Measurement (general); H.R. 3620/ S. 1969, Quality Care for Moms and Babies Act; H.R. 3522 Family Act; Contraception (general); Preeclampsia (general); Antibiotics (general); H.R. 3586, Good Samaritan Health Professionals Act, NICHD Reorganization (general); CMS Provider Penalties (general); National Health Services Corps (general); Abortion (general); H.R. 3803, District of Columbia Pain-Capable Unborn Child Protection Act; H.R. 3541, Prenatal Nondiscrimination Act of 2012; H.R. 2299, Child Interstate Abortion Notification Act; S. 2262, Advancing FASD Research, Prevention, and Services Act; CMS Health IT incentive program, meaningful use Stage 2; H.R. 2104/S. 3338, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011; H.R. 5647, Pregnant Workers Fairness Act; H.R. 4628, Interest Rate Reduction Act.

Support HR 2679, the Preemie Reauthorization Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)

HR2679/S.1440, Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act, preterm births Birth Defects Prevention, Risk Reduction, and Awareness Act, birth defects prevention. HR2194/S1221, Gestational Diabetes Act of 2011; HR3418/S1862 Stillbirth and SUID Prevention, Education and Awareness Act of 2011; maternity care.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012 H.R. 4274, BPCA and PREA Reauthorization Act of 2012 S.J. Res 37, A joint resolution to disapprove a rule promulgated by the Administrator of the EPA relating to emission standards for certain steam generating units. H.R. 4628, Interest Rate Reduction Act, Section 3 Repealing Prevention and Public Health Fund Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $70,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012 H.R. 4274, BPCA and PREA Reauthorization Act of 2012 S.J. Res 37, A joint resolution to disapprove a rule promulgated by the Administrator of the EPA relating to emission standards for certain steam generating units. H.R. 4628, Interest Rate Reduction Act, Section 3 Repealing Prevention and Public Health Fund Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $50,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

National HIV/AIDS Strategy (general); Emergency Contraception (general); H.R. 2679/S. 1440, PREEMIE. H.R. 2954, Health Equity Accountability Act; Domestic Violence(general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Personal Health Record; Abortion (general); Health IT (general); H.R. 2029/ S.1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); The Meaningful End to Defensive Medicine and Aimless Lawsuits; H.R. 2127, Newborn Act; H.R. 5/ S.1099, HEALTH Act; H.R. 452, Medicare Decisions Accountability Act of 2011; S.668, Health Care Bureaucrats Elimination Act; H.R.666, Birth Certificate Enhancement Act of 2011; H.R. 894, Maternal Health Accountability Act; Imaging (general); H.R. 2194/ S.1221, GEDI Act; H.R. 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); H.R. 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; H.R. 2085/ S. 1214; Essential Health Benefits (general); Graduate Medical Education (general); H.R. 3418/ S. 1862, Stillbirth & SUID Prevention, Education & Awareness Act; Quality Improvement Measurement (general); H.R. 3620/ S. 1969, Quality Care for Moms and Babies Act; H.R. 3522 Family Act; Contraception (general); Blunt Ammendment; Preeclampsia (general); Antibiotics (general); H.R. 3586, Good Samaritan Health Professionals Act, NICHD Reorganization (general); CMS Provider Penalties (general); National Health Services Corps (general); Abortion (general); H.R. 3803, District of Columbia Pain-Capable Unborn Child Protection Act; H.R. 3541, Prenatal Nondiscrimination Act of 2012; H.R. 2299, Child Interstate Abortion Notification Act; S. 2262, Advancing FASD Research, Prevention, and Services Act; CMS Health IT incentive program, meaningful use Stage 2; H.R. 2104/S. 3338, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011; H.R. 5647, Pregnant Workers Fairness Act; S. 3187, Food and Drug Administration Safety and Innovation Act; FDA medical device reauthorization; Medical Device User Fee and Modernization Act; H.R. 4628, Interest Rate Reduction Act.

H.R. 3; No Taxpayer Funding for Abortion Act H.R. 358; Protect Life Act H.R. 3541; The Prenatal Nondiscrimination Act Opposition Section 2713 of the Affordable Care Act (ACA), of the Institute of Medicine (IOM) developed recommendations on services that ought to be covered with no co-pay for women Labor, HHS. HHS urgining them to not expand a proposed exemption which would allow employer health plans to not cover contraceptives-HHS. Letter to Congress supporting CMS and their efforts to address fraud. Letter to FTC supporting their efforts to acknowledge scop of practice. H.R. 2465; Federal Worker's Compensation Modernization and Improvement H.R. 1179; introduced by John Fortenberry. S. 1440/H.R. 2679; PREEMIE Reauthorization Act Letter to Secretary Sebelius regarding the Essential Health Benefits. S. 3187; Food and Drug Administration Safety and Innovation Act. Provisions related to hydrocodone - containing combinations and classification. Letter to Secretary Sebelius related to the 12th Report on carcinogens. National Nurses Week Resolution Provisions related to nurse and health care worker protections. Provisions related to telemedicine. H.R. 3541; the Prenatal Nondiscrimination Act, GNE letter to CMS.

Client expense: $318,625 · Firm income: Not reported

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $689,000 · Firm income: Not reported

S. 3187/Pub. L. No. 112-144 - Food and Drug Administration Safety and Innovation Act H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to securing the pharmaceutical distribution system; enactment of federal excise tax for seasonal influenza vaccines and coverage of quadrivalent influenza vaccines under the Vaccine Injury Compensation Program; reimbursement of vaccines and related services; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates.

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR2679/S.1440, Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act, preterm births Birth Defects Prevention, Risk Reduction, and Awareness Act, birth defects prevention. HR2194/S1221, Gestational Diabetes Act of 2011; HR3418/S1862 Stillbirth and SUID Prevention, Education and Awareness Act of 2011; maternity care.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Comprehensive Sexuality Education funding (general); National HIV/AIDS Strategy (general); Postpartum Depression (general); Emergency Contraception (general); Pre-existing condition exclusion (general); H.R. 2679/S. 1440, PREEMIE. H.R. 2954, Health Equity Accountability Act; Domestic Violence(general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Personal Health Record; Abortion (general); Health IT (general); H.R. 2029/ S.1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); The Meaningful End to Defensive Medicine and Aimless Lawsuits; H.R. 2127, Newborn Act; H.R. 5/ S.1099, HEALTH Act; H.R. 452, Medicare Decisions Accountability Act of 2011; S.668, Health Care Bureaucrats Elimination Act; H.R.666, Birth Certificate Enhancement Act of 2011; H.R. 894, Maternal Health Accountability Act; Imaging (general); H.R. 2194/ S.1221, GEDI Act; H.R. 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); H.R. 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; H.R. 2085/ S. 1214; Essential Health Benefits (general); Graduate Medical Education (general); H.R. 3418/ S. 1862, Stillbirth & SUID Prevention, Education & Awareness Act; Quality Improvement Measurement (general); H.R. 3620/ S. 1969, Quality Care for Moms and Babies Act; HR 3522 Family Act; Contraception (general); Blunt Ammendment; Preeclampsia (general); Essential Health Benefits (general); Antibiotics (general); HR 3586, Good Samaritan Health Professionals Act, NICHD Reorganization (general); Medicaid Nominal Drug Price Rule (general) CMS Provider Penalties (general); National Health Service Corps, Nominations to Advisory Council; National Health Services Corps (general).

H.R. 3; No Taxpayer Funding for Abortion Act H.R. 358; Protect Life Act H.R. 3541, the Prenatal Nondiscrimination Act Opposition Section 2713 of the Affordable Care Act (ACA), of the Institute of Medicine (IOM)-developed recommendations on services that ought to be covered with no co-pay for women- Labor, HHS HHS urging them to not expand a proposed exemption which would allow employer health plans to not cover contraceptives- HHS Letter to Congress supporting CMS and their efforts to address fraud. Letter to FTC supporting their efforts to acknowledge scope of practice. H.R. 2465; Federal Worker's Compensation Modernization and Improvement H.R. 1179, introduced by John Fortenberry S.1440/H.R. 2679, PREEMIE Reauthorization Act Act Letter to Secretary Sebelius regarding the Essential Health Benefits

Client expense: $454,438 · Firm income: Not reported

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012 H.R. 4274, BPCA and PREA Reauthorization Act of 2012 S.J. Res 37, A joint resolution to disapprove a rule promulgated by the Administrator of the EPA relating to emission standards for certain steam generating units. S. 1813, Moving Ahead for Progress in the 21st Century, Senate Amendment 1520 to amend the Patient Protection and Affordable Care Act to protect rights of conscience with regard to requirements for coverage of specific items and services Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $60,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of, White House Office

H.R. 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act Reauthorization, provisions relating to pandemic influenza vaccine development H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 H.R. 2679 - Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early Reauthorization Act, provisions relating to patient safety study and report Issues related to development of legislation reauthorizing the Prescription Drug User Fee Act (PDUFA), including issues relating to approval of biologics, pediatric research incentives, supply chain integrity, drug shortages, and antibiotic incentives; CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act; reimbursement of vaccines and related services; Medicaid coverage and reimbursement; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $481,199 · Firm income: Not reported

HR2679/S.1440, Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act, preterm births Birth Defects Prevention, Risk Reduction, and Awareness Act, birth defects prevention. HR2194/S1221, Gestational Diabetes Act of 2011; HR3418/S1862 Stillbirth and SUID Prevention, Education and Awareness Act of 2011.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Comprehensive Sexuality Education funding (general); National HIV/AIDS Strategy (general); Postpartum Depression (general); Emergency Contraception (general); Pre-existing condition exclusion (general); H.R. 2659/S.1415, Birth Control Act; H.R. 2679/S. 1440, PREEMIE; H.R. 2954, Health Equity Accountability Act; Domestic Violence(general); HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Personal Health Record; Abortion (general); Health IT (general); H.R. 2029/ S.1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); The Meaningful End to Defensive Medicine and Aimless Lawsuits; H.R. 2127, Newborn Act; H.R. 5/ S.1099, HEALTH Act; H.R. 452, Medicare Decisions Accountability Act of 2011; S.668, Health Care Bureaucrats Elimination Act; H.R.666, Birth Certificate Enhancement Act of 2011; H.R. 894, Maternal Health Accountability Act; Imaging (general); H.R. 2194/ S.1221, GEDI Act; H.R. 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); H.R. 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; H.R. 2085/ S. 1214 Military Access to Reproductive Care and Health for Military Women Act; Essential Health Benefits (general); Graduate Medical Education (general); H.R. 3418/ S. 1862, Stillbirth & SUID Prevention, Education & Awareness Act; Quality Improvement Measurement (general); Birth Control Access (general); H.R. 3620/ S. 1969, Quality Care for Moms and Babies Act.

Client expense: $237,170 · Firm income: Not reported

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. S 365, HRes 384, and H Con. Res 70 - work on the Budget Control Act of 2011

Client expense: $729,381 · Firm income: Not reported

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. S 365, HRes 384, and H Con. Res 70 - work on the Budget Control Act of 2011

Client expense: $729,381 · Firm income: Not reported

Preeclampsia Research; National Health Calendar; Preemie Act (H.R. 2679, S. 1440); Birth Defects Prevention, Risk Reduction, and Awareness Act (H.R. 2029).

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH)

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $45,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

HR2679/S.1440, Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act, preterm births Birth Defects Prevention, Risk Reduction, and Awareness Act, birth defects prevention. HR2194/S1221, Gestational Diabetes Act of 2011; HR3418/S1862 Stillbirth and SUID Prevention, Education and Awareness Act of 2011.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 2465; Federal Worker's Compensation Modernization and Improvement Act H.R. 3; No Taxpayer Funding for Abortion Act H.R. 358; Protect Life Act Section 2713 of the Affordable Care Act (ACA), of the Institute of Medicine (IOM)-developed recommendations on services that ought to be covered with no co-pay for women- Labor, HHS H.R. 1179, introduced by John Fortenberry S.1440/H.R. 2679, PREEMIE Reauthorization Act Summary Benefits and Coverage Rule- White House Letter HHS urging them to not expand a proposed exemption which would allow employer health plans to not cover contraceptives- HHS Support for resolution honoring General Hazel Johnson-Brown. Letter to HHS regarding the Essential Benefits Package Letter to the President regarding the Religion Employer exemption Interim Final Rule.

Client expense: $464,666 · Firm income: Not reported

S. 1440/H.R. 2679, the Preemie Reauthorization Act general provisions related to the bill. H.R. xxxx, the Enhancing Simulation Act general provisions related to potential legislation on simulation centers. General provisions related to potential reductions in the Medicare and Medicaid budgets including GME/IME and the Medicaid assessment. H.R. 2005, the Combating Autism Act provisions related to the programs reauthorization. General provisions related to biomedical research and the translation into clinical practice.

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

H.R. xxxx, the Enhancing Simulation Act general provisions related to potential legislation on simulation centers. S. 1440/H.R. 2679, the Preemie Reauthorization Act general provisions related to the bill. General provisions related to NIH funding. H.R. 2005, the Combating Autism Act provisions related to the programs reauthorization.

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Comprehensive Sexuality Education funding (general); National HIV/AIDS Strategy (general); Postpartum Depression (general); Emergency Contraception (general); Pre-existing condition exclusion (general); Stillbirth and SIDS Prevention, Education and Awareness Act of 2011; H.R. 2659/S.1415, Birth Control Act; H.R. 2679/S. 1440, PREEMIE; HIPAA Privacy Rule accounting for disclosures under HITECH Act; H.R. 2954, Health Equity Accountability Act; H.R. 3003, Congressional Gold Medal to Dr. Balazs "Ernie" Bodai; Preventive Care (general); Domestic Violence(general); Medicaid and SCHIP Coverage and Reimbursement; HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Personal Health Record; Abortion (general); Health IT (general); H.R. 2029/ S.1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); The Meaningful End to Defensive Medicine and Aimless Lawsuits; H.R. 2127, Newborn Act; Improve Maternity Care Quality; Healthy Hunger-Free Kids; H.R. 5/ S.1099, HEALTH Act; H.R. 452, Medicare Decisions Accountability Act of 2011; S.668, Health Care Bureaucrats Elimination Act; H.R.666, Birth Certificate Enhancement Act of 2011; H.R. 358, Protect Life Act; H.R. 894, Maternal Health Accountability Act; Imaging (general); H.R. 2194/ S.1221, GEDI Act; State Paid Leave (general); H.R. 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); H.R. 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; Military Access to Reproductive Care and Health for Military Women Act; FDA Comments on Scientific Evaluation of Modified Risk Tobacco Products.

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. S 365, HRes 384, and H Con. Res 70 - work on the Budget Control Act of 2011

Client expense: $729,381 · Firm income: Not reported

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA

Client expense: $50,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

HR2679/S.1440, Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act, preterm births Birth Defects Prevention, Risk Reduction, and Awareness Act, birth defects prevention.

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE